A clinical review on chronic obstructive pulmonary disease

Chronic Obstructive Pulmonary Disease (COPD) is a collective term for chronic lung diseases that obstruct airflow and make breathing difficult. The primary causes of COPD are exposure to harmful chemicals, particularly from smoking, which damages the lining of the lungs and airways. This damage increases mucus production, leading to a chronic productive cough that can persist for several months each year over two consecutive years. The two main conditions that contribute to COPD are emphysema and chronic bronchitis, often coexisting with varying severity among patients.

Epidemiology

Globally, COPD is a major public health concern with increasing prevalence and mortality rates. The disease burden varies significantly across different regions, with India accounting for a substantial and rising portion of global cases. Estimates suggest that over 30 million people in India are affected by COPD, with a high morbidity rate. Studies like the Burden of Obstructive Lung Disease (BOLD) report provide crucial data on the prevalence and impact of COPD, highlighting regional variations and the significant burden in countries like India and Bangladesh.

Symptoms

The primary symptoms of COPD include persistent respiratory symptoms such as chronic cough, increased mucus production, and difficulty in breathing. These symptoms often worsen over time and can lead to significant limitations in daily activities and overall quality of life. The progression of symptoms can vary, with some individuals experiencing frequent exacerbations that lead to severe health complications.

Mechanism

At the anatomical level, emphysema is characterized by the destruction of alveolar sacs and ducts distal to the terminal bronchiole, leading to abnormally large distal airways. Chronic bronchitis, on the other hand, involves inflammation and overgrowth of bronchial mucous glands and goblet cells in the bronchioles. Both conditions contribute to the airflow limitation and respiratory symptoms observed in COPD patients.

Diagnosis

The diagnosis of COPD typically involves a combination of clinical assessment, patient history, and diagnostic tests such as spirometry. Spirometry measures lung function by assessing the volume of air a person can exhale forcefully in one second (FEV1) and the total volume of air exhaled (FVC). The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines classify COPD severity into four grades based on spirometry results, ranging from mild (GOLD 1) to very severe (GOLD 4).

Traditional Therapies

In addition to conventional pharmacological treatments, traditional therapies have gained attention in COPD management. Complementary and alternative medicine practices, such as acupuncture, herbal supplements, and yoga, are explored for their potential benefits in alleviating COPD symptoms. While the evidence supporting these interventions is still evolving, they offer promising adjunctive options for holistic COPD care.

COPD in India

India has a high prevalence of COPD, with significant regional variations. Factors contributing to the high burden include smoking cigarettes and bidis, exposure to environmental tobacco smoke, and air pollution from burning fuel for cooking and heating. Rural areas often report higher prevalence rates compared to urban regions. Effective management strategies in India must consider these regional differences and address the specific risk factors prevalent in different communities.

Management

Managing COPD involves a multidimensional approach targeting symptom relief, improving lung function, and enhancing overall quality of life. Pharmacological interventions such as bronchodilators and anti-inflammatory agents play a pivotal role. Non-pharmacological strategies, including pulmonary rehabilitation, nutritional support, and mental health considerations, are also essential components of comprehensive COPD care. Patient education and self-management strategies empower individuals to manage their condition effectively and improve their quality of life.

Conclusions

In conclusion, COPD is a significant public health issue with a growing global burden. Effective management requires a comprehensive approach that includes both conventional and traditional therapies. Addressing the specific risk factors and regional variations, particularly in countries like India, is crucial for improving COPD outcomes. By integrating pharmacological treatments, non-pharmacological strategies, and holistic care approaches, we can enhance the quality of life for individuals affected by COPD and reduce the overall disease burden.

Full text:

https://www.xiahepublishing.com/2835-6357/FIM-2023-00026

The study was recently published in the Future Integrative Medicine.

Future Integrative Medicine (FIM) publishes both basic and clinical research, including but not limited to randomized controlled trials, intervention studies, cohort studies, observational studies, qualitative and mixed method studies, animal studies, and systematic reviews.

Follow us on X: @xiahepublishing

Follow us on LinkedIn:  Xia & He Publishing Inc.